Nasdaq smmt.

Oxford, UK, and Cambridge, MA, US, 23 January 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that the Biomedical ...SMMT Summit Therapeutics Inc Form PRE 14A - Other preliminary proxy statements. ... (NASDAQ:SMMT) Historical Stock Chart From Oct 2023 to Nov 2023 Summit Therapeutics (NASDAQ:SMMT)NASDAQ: SMMT Summit Therapeutics. Market Cap. $1B. Today's Change (0.54%) $0.01. ... Shares of Summit Therapeutics (SMMT 0.54%), a clinical-stage biopharmaceutical company, tanked Monday morning ...OXFORD, United Kingdom, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces further positive findings from PhaseOut DMD, a Phase 2 open-label, multi-centre ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to help you make...

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.Investors eyeing a purchase of Summit Therapeutics Inc (Symbol: SMMT) stock, but cautious about paying the going market price of $2.52/share, might benefit from considering selling puts among the ...Oxford, UK, and Cambridge, MA, US, 17 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it highlighted the potential of its preclinical new class antibiotic, SMT ...

há 5 dias ... Find the latest dividend history for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.

OXFORD, United Kingdom, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Stocks that have clustered insider purchases in March include The Charles Schwab Corporation (NYSE:SCHW), Keurig Dr Pepper Inc.(NASDAQ:KDP), and Summit Therapeutics PLC (NASDAQ:SMMT). 7. GuruFocusWebSummit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Cambridge, MA, November 16, 2020 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the third quarter and nine ...WebSummit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …Web

MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...Web

The new research reports from Fundamental Markets, available for free download at the links above, examine Honda Motor Co., Ltd. (NYSE:HMC), Summit Therapeutics PLC (NASDAQ:SMMT), Atlassian ...Web

BABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in …Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.Summit Therapeutics Inc. Common Stock (SMMT) Nasdaq Listed. DATA AS OF Nov 26, 2021. 0. Add to Watchlist. Add to Portfolio. SMMT SMMT HISTORICAL DATA. Summit Therapeutics Inc. Common Stock (SMMT) Nasdaq Listed. DATA AS OF Nov 26, 2021. 0. Add to Watchlist. Add to Portfolio. SMMT SMMT HISTORICAL DATA.Share Price. NASDAQ: SMMT. 2.25USD 0.12. At 04/12/2023 19:25. More information. SEC Filings. Current report filing. VIEW FILING. Quarterly report pursuant to ...CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical ...

Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript May 11, 2023 Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call.Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Summit Therapeutics was founded by Stephen Graham Davies and ...Follow. Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its ...The company earned $0.27 million during the quarter. Summit Therapeutics has generated ($1.55) earnings per share over the last year ( ($1.55) diluted earnings per share). Summit Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior ...3 de nov. de 2023 ... (NASDAQ: SMMT) (“Summit”) will present data for the novel, potential first-in-class investigational bispecific antibody, ivonescimab (AK112 ...

Sarepta Ian Estepan: Tel: 617-274-4052 [email protected] W2O Group Brian Reid: Tel: 212-257-6725 [email protected]

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ...Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Web3 de nov. de 2023 ... (NASDAQ: SMMT) (“Summit”) will present data for the novel, potential first-in-class investigational bispecific antibody, ivonescimab (AK112 ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Oxford, UK, and Cambridge, MA, US, 14 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today presented in vivo proof of concept ...Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of ...Stocks that have clustered insider purchases in March include The Charles Schwab Corporation (NYSE:SCHW), Keurig Dr Pepper Inc.(NASDAQ:KDP), and Summit Therapeutics PLC (NASDAQ:SMMT). 7. GuruFocusWeb

Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research ...Web

Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...

OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week Read full article Simply Wall StCambridge, MA, July 12, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying three preeminent ePosters at the prestigious 31st ...WebSummit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript May 11, 2023 Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call.OXFORD, United Kingdom, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Summit (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to …Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual ...See the latest Summit Therapeutics Inc Ordinary Shares stock price (SMMT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 28, 2023 · Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.Cambridge, Massachusetts, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it will present the Company’s vision ...Instagram:https://instagram. cowz etf holdingsmaster works stockcymabay therapeutics incbest python course online Oxford, UK, and Cambridge, MA, US, July 13, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces the publication of data from the Phase 2 clinical trial of the company’s precision ... otcmkts abmldchat ai without filter The Society of Motor Manufacturers & Traders (SMMT) supports and promotes the interests of the UK automotive industry at home and abroad.Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing. san francisco 49ers joe montana jersey Shares of Summit Therapeutics ( SMMT 4.93%) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which ...Employees. CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision …